Advertisement

Reactions Weekly

, Volume 1635, Issue 1, pp 240–240 | Cite as

Pembrolizumab

Large-vessel vasculitis: case report
Case report
  • 23 Downloads

Reference

  1. Pinkston O, et al. Type and frequency of immune-related adverse reactions in patients treated with pembrolizumab (keytruda), a monoclonal antibody directed against PD-1, in advanced melanoma at a single institution. Arthritis and Rheumatology 68 (Suppl. S10): 1679-1681 abstr. 1340, Oct 2016. Available from: URL: http://do.org/10.1002/art.39977 [abstract] - USA

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations